Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
311 studies found for:    "Emtricitabine"[TREATMENT] AND HIV [CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
2 Completed An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Condition: HIV Infections
Intervention: Drug: Emtricitabine
3 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
4 Not yet recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
5 Withdrawn Raltegravir Activity In Lymphoid Tissues
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Efavirenz + Tenofovir DF/Emtricitabine;   Drug: Raltegravir + Tenofovir DF/Emtricitabine;   Procedure: Colonoscopy with biopsies;   Procedure: Inguinal Lymph Node Excision
6 Unknown  Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Emtricitabine;   Drug: Stavudine
7 Completed Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: tenofovir DF;   Drug: emtricitabine
8 Completed
Has Results
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: FTC/TDF;   Drug: FTC/TDF/EFV;   Drug: Lamivudine/zidovudine
9 Completed Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir and Lopinavir/ritonavir;   Drug: Raltegravir, emtricitabine, tenofovir
10 Completed Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
11 Completed
Has Results
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Condition: HIV Infection
Interventions: Drug: emtricitabine/tenofovir;   Drug: abacavir/lamivudine
12 Completed Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Atripla
13 Completed Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: tenofovir;   Drug: emtricitabine;   Drug: zidovudine;   Drug: efavirenz
14 Recruiting PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: Tenofovir/emtricitabine
15 Active, not recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
16 Completed
Has Results
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir/lamivudine and efavirenz;   Drug: Tenofovir/Emtricitabine and efavirenz
17 Unknown  Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Emtricitabine/tenofovir/efavirenz
18 Recruiting Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, Emtricitabine, Lopinavir/r;   Drug: Tenofovir, Emtricitabine, Raltegravir
19 Completed Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection
Conditions: Hepatitis B Virus;   HIV Infections
Intervention: Drug: Emtricitabine
20 Completed
Has Results
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate;   Drug: Zidovudine;   Drug: Emtricitabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years